LITS CIK: 1262104

Lite Strategy, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26

Assets

(positive)
Change from FY22 to FY26
millions USD
FY22:
167
FY23:
108
FY24:
40.8
FY25:
18.3
FY26:
6.14
(positive)
Change from FY22 to FY26
millions USD
FY22:
10.7
FY23:
13.3
FY24:
0.61
FY25:
0
FY26:
36.6
Total assets
Change from FY22 to FY26
millions USD
FY22:
178
FY23:
121
FY24:
41.4
FY25:
18.3
FY26:
42.7

Liabilities & Equity

(negative)
Change from FY22 to FY26
millions USD
FY22:
24.4
FY23:
20.3
FY24:
8.36
FY25:
1.35
FY26:
1.07
(negative)
Change from FY22 to FY26
millions USD
FY22:
101
FY23:
75.8
FY24:
0
FY25:
0
FY26:
0
(positive)
Change from FY22 to FY26
millions USD
FY22:
52.4
FY23:
24.6
FY24:
33.0
FY25:
16.9
FY26:
41.6
Total liabilities & equity
Change from FY22 to FY26
millions USD
FY22:
178
FY23:
121
FY24:
41.4
FY25:
18.3
FY26:
42.7

All amounts in millions USD Data source:SEC EDGAR